3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
15
Colorectal Neoplasms
15
Pancreatic Neoplasms
11
Colonic Neoplasms
9
Carcinoma, Hepatocellular
9
Esophageal Neoplasms
6
Rectal Neoplasms
5
Colorectal Neoplasms, Hereditary Nonpolyposis
4
Anus Neoplasms
4
Neoplasms
3
Gastrointestinal Stromal Tumors
3
Gastrointestinal Neoplasms
3
Gallbladder Neoplasms
3
Vulvar Neoplasms
2
Uterine Cervical Neoplasms
2
Squamous Intraepithelial Lesions
2
Peritoneal Neoplasms
2
Ovarian Neoplasms
2
Melanoma
2
Endometrial Neoplasms
2
Cholangiocarcinoma
2
Bile Duct Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Interventions
Paclitaxel
11
Fluorouracil
10
pembrolizumab
9
Cisplatin
9
Radiotherapy
7
Carboplatin
6
Esophagectomy
5
Nivolumab
4
Drug Therapy
4
Radiotherapy, Intensity-Modulated
3
Leucovorin
3
Chemoradiotherapy
3
Cetuximab
3
Capecitabine
3
durvalumab
2
atezolizumab
2
Oxaliplatin
2
Ipilimumab
2
spartalizumab
1
sintilimab
1
selinexor
1
regorafenib
1
prexasertib
1
osimertinib
1
niraparib
1
nilotinib
1
nedaplatin
1
nanocis
1
fludarabine
1
cobimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Observation
×
Gastrointestinal
×
Clear all
NCT02503111
2022-06-13
HPV-SAVE
University Health Network, Toronto
Phase NA
Terminated
71 enrolled